Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

Abstract

Melatonin and melatonin agonists offer novel treatments for sleep and mood disorders, particularly where circadian misalignment is also present. The therapies offer both phase-shifting and sleep-promoting effects and have shown potential to treat advanced and delayed sleep-wake phase disorder, non-24-h sleep-wake cycle, jetlag, shift work disorder, insomnia, seasonal affective disorder and major depressive disorder.

Original languageEnglish
Title of host publicationHandbook of Experimental Pharmacology
EditorsHans-Peter Landolt, Derk-Jan Dijk
Place of PublicationCham, Switzerland
PublisherSpringer
Pages305-319
Number of pages15
ISBN (Electronic)9783030112721
ISBN (Print)9783030112707
DOIs
Publication statusPublished - 2019

Publication series

NameHandbook of Experimental Pharmacology
Volume253
ISSN (Print)0171-2004
ISSN (Electronic)1865-0325

Keywords

  • Agomelatine
  • Circadian rhythm
  • Circadin
  • Major depressive disorder
  • Melatonin
  • Melatonin agonist
  • Mood
  • Ramelteon
  • Sleep
  • Tasimelteon

Cite this

Alston, M., Cain, S. W., & Rajaratnam, S. M. W. (2019). Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood. In H-P. Landolt, & D-J. Dijk (Eds.), Handbook of Experimental Pharmacology (pp. 305-319). (Handbook of Experimental Pharmacology; Vol. 253). Cham, Switzerland: Springer. https://doi.org/10.1007/164_2018_139
Alston, Megan ; Cain, Sean W. ; Rajaratnam, Shantha M.W. / Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood. Handbook of Experimental Pharmacology. editor / Hans-Peter Landolt ; Derk-Jan Dijk. Cham, Switzerland : Springer, 2019. pp. 305-319 (Handbook of Experimental Pharmacology).
@inbook{2b9e009a69ed4af5914e934e15699e52,
title = "Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood",
abstract = "Melatonin and melatonin agonists offer novel treatments for sleep and mood disorders, particularly where circadian misalignment is also present. The therapies offer both phase-shifting and sleep-promoting effects and have shown potential to treat advanced and delayed sleep-wake phase disorder, non-24-h sleep-wake cycle, jetlag, shift work disorder, insomnia, seasonal affective disorder and major depressive disorder.",
keywords = "Agomelatine, Circadian rhythm, Circadin, Major depressive disorder, Melatonin, Melatonin agonist, Mood, Ramelteon, Sleep, Tasimelteon",
author = "Megan Alston and Cain, {Sean W.} and Rajaratnam, {Shantha M.W.}",
year = "2019",
doi = "10.1007/164_2018_139",
language = "English",
isbn = "9783030112707",
series = "Handbook of Experimental Pharmacology",
publisher = "Springer",
pages = "305--319",
editor = "Landolt, {Hans-Peter } and Derk-Jan Dijk",
booktitle = "Handbook of Experimental Pharmacology",

}

Alston, M, Cain, SW & Rajaratnam, SMW 2019, Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood. in H-P Landolt & D-J Dijk (eds), Handbook of Experimental Pharmacology. Handbook of Experimental Pharmacology, vol. 253, Springer, Cham, Switzerland, pp. 305-319. https://doi.org/10.1007/164_2018_139

Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood. / Alston, Megan; Cain, Sean W.; Rajaratnam, Shantha M.W.

Handbook of Experimental Pharmacology. ed. / Hans-Peter Landolt; Derk-Jan Dijk. Cham, Switzerland : Springer, 2019. p. 305-319 (Handbook of Experimental Pharmacology; Vol. 253).

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Other

TY - CHAP

T1 - Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood

AU - Alston, Megan

AU - Cain, Sean W.

AU - Rajaratnam, Shantha M.W.

PY - 2019

Y1 - 2019

N2 - Melatonin and melatonin agonists offer novel treatments for sleep and mood disorders, particularly where circadian misalignment is also present. The therapies offer both phase-shifting and sleep-promoting effects and have shown potential to treat advanced and delayed sleep-wake phase disorder, non-24-h sleep-wake cycle, jetlag, shift work disorder, insomnia, seasonal affective disorder and major depressive disorder.

AB - Melatonin and melatonin agonists offer novel treatments for sleep and mood disorders, particularly where circadian misalignment is also present. The therapies offer both phase-shifting and sleep-promoting effects and have shown potential to treat advanced and delayed sleep-wake phase disorder, non-24-h sleep-wake cycle, jetlag, shift work disorder, insomnia, seasonal affective disorder and major depressive disorder.

KW - Agomelatine

KW - Circadian rhythm

KW - Circadin

KW - Major depressive disorder

KW - Melatonin

KW - Melatonin agonist

KW - Mood

KW - Ramelteon

KW - Sleep

KW - Tasimelteon

UR - http://www.scopus.com/inward/record.url?scp=85071783349&partnerID=8YFLogxK

U2 - 10.1007/164_2018_139

DO - 10.1007/164_2018_139

M3 - Chapter (Book)

SN - 9783030112707

T3 - Handbook of Experimental Pharmacology

SP - 305

EP - 319

BT - Handbook of Experimental Pharmacology

A2 - Landolt, Hans-Peter

A2 - Dijk, Derk-Jan

PB - Springer

CY - Cham, Switzerland

ER -

Alston M, Cain SW, Rajaratnam SMW. Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood. In Landolt H-P, Dijk D-J, editors, Handbook of Experimental Pharmacology. Cham, Switzerland: Springer. 2019. p. 305-319. (Handbook of Experimental Pharmacology). https://doi.org/10.1007/164_2018_139